Motonobu Maruo

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. So Yamaki · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
2. Sohei Satoi · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
3. Tsukasa Ikeura · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
4. Takashi Ito · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
5. Makoto Naganuma · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
6. Koh Nakamaru · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
7. Ayaka Takaori · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
8. Daisuke Hashimoto · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
9. Hidetaka Miyazaki · 2 shared papers, 2024–2026 · strength 0.40
   • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
   • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗
10. Masashi Kanai · 1 shared paper, 2026 · strength 0.23
    • Paper Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Ca… DOI 10.1016/j.gastha.2025.100779↗
11. Makoto Takaoka · 1 shared paper, 2024 · strength 0.16
    • Paper Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or … DOI 10.1016/j.pan.2024.06.001↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.